mercredi 20 mai 2015

Onco Actu du 20 mai 2015

1. Biologie

Mechanism Uncovered for Mutations Common to Cancer Cells [GEN]

Annals of Oncology Press Release: World First – Researchers Quantify the Proportion of Different Genetic Mutations Contained within Individual Bowel Cancers [ESMO]

3.1 Tabac

Is nicotine all bad? [Reuters]

4. Dépistage, diagnostic et pronostic

Doctor group seeks to clear confusion in cancer screening [Fox News]

4.12 Biopsies liquides

Are We Ready to Trust Liquid Biopsies? with Milena Cankovic, Henry Ford Hospital [Mendelspod]

Microchip captures clusters of circulating tumor cells - NIH study [NIH]

4.9 Dép., diag. & prono. - Sein

Dense Breasts Are Just One Part Of The Cancer Risk Calculus [NPR]

Breast density should not be sole factor to govern cancer screening, study says [The Guardian]

5. Traitements

Chemo before surgery benefits patients with advanced ovarian cancer [Cancer Research UK]

Hitting the Right Target? Lab Studies Suggest Epigenetic Drug May Fight Childhood Brain Cancer [NIH Director's Blog]

5.2 Pharma

Robert Gentleman on His Goals for Drug Discovery at 23andMe [Bio-IT World]

5.2.1 Pharma - Partenariats

BioNTech, Genmab Launch Up-to-$15M Cancer Immunotherapy Collaboration [GEN]

5.2.2 Pharma - Fusions & Acquisitions

Ipsen strengthens its presence in the oncology field with the acquisition of OctreoPharm Sciences, a company developing innovative radiopharmaceuticals for the diagnosis and treatment of neuroendocrine tumours [Ipsen]

Pfizer Rumors, Again [In the Pipeline]

5.9 AACR

Clinical Trials Highlighted at the AACR Annual Meeting 2015 [AACR]

6.1 Observation

Family breast cancer 'as treatable' as other tumours [BBC News]

6.11 Patients

Cancer patients get chance to create a musical legacy [Reuters]

6.3 Associations

4 Cancer Charities Are Accused of Fraud [NY Times]

Four U.S. cancer charities charged; two settle [Reuters]

6.4 Médico-éco

Dame Sally Davies: ‘We can make research a statement, not a question’ [Cancer Research UK]

NHS pressures at risk of stifling cancer research [Cancer Research UK]

6.6 Publications

F1000 and ORCID Partner to Launch Standard for Citing Peer Review Activities [ORCID]

Are current scholarly metrics leading us away from research transparency? [BioMed Central blog]

Reproducibility crisis: Blame it on the antibodies [Nature News & Comment]

6.7.1 Bioinformatique

To handle big data, shrink it [MIT News]

6.7.2 Applis

Hospital Pilots Chemotherapy Apple Watch App in London [HIT]

MD Anderson Pilots Apple Watch for Breast Cancer Treatment [HIT]